Eurostars is built for international R&D projects led by innovative SMEs. The application has to show why the partners need one another, why the technology is genuinely innovative yet achievable, and why a credible commercial opportunity can emerge from the project.
Applications are assessed by independent experts and the strongest eligible proposals progress to an Independent Evaluation Panel ranking.
Eurostars asks whether the consortium can execute, whether the result can matter commercially and whether the R&D challenge is both innovative and technically credible.
Experts look at consortium quality, added value through cooperation, project management and planning, and whether the cost structure is reasonable.
Market size, access and risk, competitive advantage, commercialisation plans and wider economic, environmental or societal impact all need credible evidence.
The application should show the degree of innovation, new applied knowledge, technical challenge, achievability and risk without making the project look either trivial or impossible.
Eurostars rewards practical coherence. Weaknesses become visible quickly when consortium, technology and market sections tell different versions of the project.
The consortium meets the formal rules but the added value of cooperation is weak.
Project management is described in generic terms with little decision logic around technical risk.
Competitive advantage is asserted without quantified comparison or customer relevance.
Commercialisation plans start after the project but the route, owner and timing are unclear.
The technology is described as highly innovative while technical achievability is under-explained.
The cost structure looks plausible but is not clearly connected to the work needed to reach the result.
Claims stay generic instead of naming actors, baselines, target values, timing, quantities or accountable owners.
Important claims rely on assertion instead of recognised references, comparable evidence or verifiable proof points.
The evaluation follows the practical questions an expert needs to answer before giving a high score and a convincing justification.
Ruthless checks whether each partner contribution, task and cost explains why the consortium is stronger together.
The review looks for the right balance between innovation, technical challenge, achievability and risk management.
Market access, competition, customer value and post-project commercialisation are checked for gaps and unsupported jumps.
The Priority Action Plan helps teams fix the highest-impact weaknesses before coordinating another full consortium review.
Deeper context for teams preparing, reviewing or revising this type of application.
A practical guide to replacing vague benefits with measurable claims that an evaluator can assess.
Why credible justification matters across technical, market and implementation claims.
Why polished language cannot rescue weak project logic, evidence or fundability.
Find the weak logic, evidence gaps and revision priorities while there is still time to change them.
We use essential cookies to make the site work. Optional cookies, such as analytics, are disabled by default. You can accept, reject, or configure your preferences.
See: Privacy Policy